About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Signs Development Agreement for TPM Oxymorphone Patch in Japan

August 22, 2017

Click here to read more

Post navigation

Phosphagenics Sells BioElixia Beauty Brand to Pure Beauty Australia

June 2017 Half Year Financial Report and Appendix 4D

Related Posts

CEO Update – Teleconference

March 20, 2018

Phosphagenics Signs Japanese License Option Agreement and R&D Alliance

April 29, 2016

Oxymorphone Patch Program Update

May 14, 2015

Recent Posts

US & EU Patent Allowances for CBD Soft-Gel Formulation
December 3, 2025
Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.